STAT+: FDA pilot offers generative AI medical devices a path to patients before they are authorized
Reported by STAT News · all stories from statnews.com
Editorial digest
A new FDA initiative aims to expedite patient access to generative artificial intelligence medical devices. This pilot program permits their use even before full regulatory clearance.
Digests are written in our own words from the publisher's headline — we never reproduce article text. Read the original for the full reporting.
Read the full story at STAT News →More like this
Other stories our editors tagged with the same themes.
- Trusted health newsroom8/25/2026
STAT+: FDA promises new AI guidance, and what happened at Epic’s UGM
The FDA will issue new AI regulations; Epic's user meeting also had significant updates.
- Trusted health newsroom9/1/2026
STAT+: FDA clears Stryker’s ‘surgical cockpit’ that uses Apple’s VR headset, Vision Pro
Stryker's system for surgery, using Apple Vision Pro, received FDA clearance.
- Trusted health newsroom8/27/2026
STAT+: CMS plans launch event for ACCESS, the Medicare chronic care pilot
CMS is preparing an event for its new chronic care pilot, ACCESS.
- Trusted health newsroom8/11/2026
STAT+: A RAPID proposal for breakthrough coverage, and nurses push back on AI
A proposal for rapid breakthrough coverage emerges as nurses challenge AI.
- Trusted health newsroom8/24/2026
STAT+: FDA digital health leader promises generative AI regulatory guidance is coming
FDA digital health head confirms generative AI regulatory guidelines are in development.
- Trusted health newsroom8/18/2026
FDA seeks feedback on potential regulatory approaches for generative AI-enabled medical devices | AHA News - American Hospital Association
The FDA seeks input on regulating generative AI for medical devices.